Test your basic knowledge |

First Aid Basics

Subjects : health-sciences, first-aid

Instructions:

Answer 50 questions in 15 minutes.
If you are not ready to take this test, you can study here.
Match each statement with the correct term.
Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.

This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.

1. Colorectal cancer (assoc with FAP) 5q tumor suppressor
Paget's bone disease
calcitonin
APC gene
Primary tumors that met to brain

2. Blood (leukemia)
Alkylating agents target
ras gene
ulcerative colitis
Necrosis

3. Infections - inflammation - cancer - pregnancy - SLE
bcl -2 gene
radiation exposure
intrinsic apoptosis
causes of increased ESR

4. Tumor marker: thyroid medullary carcinoma
calcitonin
smooth muscle benign tumor
Alkylating agents target
fat benign tumor

5. Neuroblastoma transcription factor (oncogene)
Leukocyte extravasation: rolling
acanthosis nigricans (hyperpig and epidermal thickening)
ras gene
N- myc gene

6. Sarcoma
secondary amyloidosis (reactive systemic)
blood cell malignant tumors
cirrosis (alcohol - hepB or C)
malignant mesenchyme tumor (general)

7. Mature teratoma in men or malignant teratoma in M/F
malignant >1 cell type tumor
CA-19-9
bone benign tumor
BRAC2 gene

8. AL
primary amyloidosis
CCl4 target
Colon and rectal cancer incidence
Leukocyte extravasation: rolling

9. Melanoma 9p tumor suppressor
Barrett's esophagus (chronic GI reflux)
DPC gene
bone malignant tumor
p16 gene

10. Breast and ovarian cancer 17q tumor suppressor (DNA repair protein)
paraneoplastic effects of small cell lung carcinoma
BRCA1 gene
beta - hCG
paraneoplastic effects of leukemias and lymphomas

11. Rhabdomyosarcoma
Napthalene (aniline) dyes target
skeletal muscle malignant tumor
benign epithelial tumor
PSA

12. Tumor marker: (Normal in fetus). Hepatocellular carcinomas. Nonseminomatous germ cell tumors of the testis.
lung cancer incidence/mortality
NF1 gene
alpha - fetoprotein
CA-19-9

13. Malignant melanoma
secondary amyloidosis (reactive systemic)
dysplastic nevus
Leukocyte extravasation: tight binding
NF1 gene

14. Neurofibromatosis type 2 22q tumor suppressor (key type 2=22)
Neoplasm associated with xeroderma pigmentosum (albinism)
secondary amyloidosis (reactive systemic)
ras gene
NF2 gene

15. Visceral malignancy (stomach - lung - breast - uterus)
acanthosis nigricans (hyperpig and epidermal thickening)
CEA
Barrett's esophagus (chronic GI reflux)
granulomatous disease

16. Female 13%/23% and rising Male 16%/33% (mortality has plateaued)
ret gene
Chronic inflammatory mediators
Resolution of inflammation
lung cancer incidence/mortality

17. Colonic adenocarcinoma
ulcerative colitis
vinyl chloride target
Alk - phos
breast cancer incidence/mortality

18. Tumor marker: pancreatic adenocarcinoma
CA-19-9
lung cancer incidence/mortality
Bombesin
skeletal muscle benign tumor

19. Liver (angiosarcoma)
Leukocyte extravasation: rolling
AIDS
vinyl chloride target
DCC gene

20. Hyperplasia - metaplasia - dysplasia
NF1 gene
Necrosis
Red (hemorrhagic) infarcts
Reversible - plasias

21. Squamous cell carcinoma of skin
TRAP
Neoplasm associated with actinic keratosis
smooth muscle benign tumor
lung cancer incidence/mortality

22. Vascular: E and P- selectin Leukocyte: Sialyl Lewis
ret gene
Napthalene (aniline) dyes target
causes of increased ESR
Leukocyte extravasation: rolling

23. Liposarcoma
fat malignant tumor
Rb gene
Free radical cell damage
smooth muscle malignant tumor

24. Ligand - receptor interactions. Release of perforin and granzyme B.
benign epithelial tumor
paraneoplastic effects of renal cell carcinoma - hemangioblastoma
extrinsic apoptosis
blood vessels benign tumor

25. Adenoma - papilloma
benign epithelial tumor
bone benign tumor
blood cell malignant tumors
p53 gene

26. Tumor marker: neuroblastoma - lung and gastric cancer
beta - hCG
ulcerative colitis
Bombesin
c - kit gene

27. Tumor marker: carcinoembryonic Ag Very nonspecific
skeletal muscle malignant tumor
prostate cancer incidence/mortality
Reversible - plasias
CEA

28. Sarcoma - papillary thyroid cancer
alpha - fetoprotein
smooth muscle benign tumor
radiation exposure
Napthalene (aniline) dyes target

29. Erythropoietin
fat benign tumor
CA-125
paraneoplastic effects of renal cell carcinoma - hemangioblastoma
Leukocyte extravasation: tight binding

30. Lung - breast - skin (melanoma) - kidney (renal cell carcinoma) - GI.50% brain tumors are from mets
Necrosis
skeletal muscle benign tumor
Rb gene
Primary tumors that met to brain

31. Rhabdomyoma
p53 gene
skeletal muscle benign tumor
smooth muscle malignant tumor
Primary tumors that met to bone

32. Neutrophils (eos in the gut) - plus other granular leukocytes and antibodies.
Acute inflammatory mediators
nitrosamines (smoked foods) target
paraneoplastic effects of small cell lung carcinoma
Barrett's esophagus (chronic GI reflux)

33. Retinoblastoma - osteosarcoma 13q tumor suppressor (blocks G1 to S phase progression)
fat malignant tumor
lung cancer incidence/mortality
secondary amyloidosis (reactive systemic)
Rb gene

34. Secondary osteosarcoma and fibrosarcoma

35. Macrophages and lymphocytes. Persistant destruction and repair.
abl gene
Chronic inflammatory mediators
iron poisoning
smooth muscle benign tumor

36. Squamous cell carcinoma of the esophagus
Prostatic acid phosphatase
Plummer - Vinson syndrome (atrophic glossitis - esophageal webs - anemia)
Necrosis
PSA

37. Hyperuricemia (excess NA turnover)
paraneoplastic effects of leukemias and lymphomas
blood cell malignant tumors
cigarette smoke target
Irreversible - plasias

38. Leukemia - lymphoma
primary amyloidosis
acanthosis nigricans (hyperpig and epidermal thickening)
blood cell malignant tumors
skeletal muscle malignant tumor

39. Lipoma
secondary amyloidosis (reactive systemic)
blood vessels malignant tumor
fat benign tumor
Primary tumors that met to brain

40. Esophageal adenocarcinoma

41. Tumor marker: melanoma - neural tumors - astrocytomas
asbestos target
S-100
beta - hCG
Neoplasm associated with tuberous sclerosis (facial angiofibroma - seizures - mental retardation)

42. Solid tissues with single blood supply. Heart - kidney and spleen.
Pale infarcts
calcitonin
CA-19-9
S-100

43. ADH
Primary tumors that met to bone
DCC gene
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
fat malignant tumor

44. Breast - ovarian and gastric carcinomas tyrosine kinase (oncogene)
acanthosis nigricans (hyperpig and epidermal thickening)
Bombesin
erb - B2 gene
Chronic inflammatory mediators

45. Skin (SqCC) - liver (angiosarcoma)
radiation exposure
arsenic target
Primary tumors that met to brain
blood vessels malignant tumor

46. Tumor marker: Screen for prostate carcinoma. Can also be elevated in BPH and prostatitis.
PSA
Red (hemorrhagic) infarcts
S-100
NF2 gene

47. Hepatocellular carcinoma
ras gene
cirrosis (alcohol - hepB or C)
CEA
dysplastic nevus

48. Enzymatic degradation and protein denaturation due to exogenous injury. Inflammatory process where intracellular components extravasate.
Red (hemorrhagic) infarcts
Necrosis
PSA
TRAP

49. Melanoma - basal cell carcinoma - and especially squamous cell carcinomas of the skin.
dysplastic nevus
Neoplasm associated with xeroderma pigmentosum (albinism)
causes of increased ESR
Alkylating agents target

50. Bladder (transitional cell carcinoma)
iron poisoning
Napthalene (aniline) dyes target
CCl4 target
DPC gene